Form 8-K · Current report
IBM 8-K, filed Oct 1, 2026
- Filed
- CIK
- 0000051143
- Accession no.
- 0000051143-26-000086
Summary
IBM elected Frank Baker, co-founder and managing partner of private equity firm Siris Capital Group, to its board of directors effective October 1, 2026, and amended its by-laws to increase the number of directors to fourteen. IBM chairman and CEO Arvind Krishna said Baker's expertise and leadership would strengthen the business and deliver value to shareholders.
Key points
- Baker joined the board's Directors and Corporate Governance Committee.
- Article III, Section 2 of IBM's by-laws was amended to raise the board size to fourteen directors.
- Baker previously was a managing director at Ripplewood Holdings and began his career in mergers and acquisitions at Goldman Sachs.
- Baker is a trustee of the University of Chicago, chairman of the board of the Robert & Ethel Kennedy Human Rights Center, and a trustee of Deerfield Academy.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02(d). Election of Directors. On October 1, 2026, IBM announced that Frank Baker, Co-founder and Managing Partner of Siris Capital Group, LLC, has been elected to the IBM Board of Directors, effective October 1, 2026. Mr. Baker joined the Directors and Corporate Governance Committee. IBM’s compensatory and other arrangements for non-management directors are set forth in the company’s Proxy Statement, dated March 10, 2026. The press release is attached as Exhibit 99.1 of this Form 8-K. Item 5.03(a). Amendment to By-laws. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.